Novo Nordisk Aktie - NOVA

Professionelle Tools für Privatanleger.

Premium

Current Price

81,40

Gebot

81,20

Fragen

81,60

Volumen

79.629

72,40 Tagesbereich 100,50

0,00 52-Wochen-Bereich 0,00

Marktkapitalisierung

363,225B

Handelsende

100,00

Handelsbeginn

100,00

Letzte Trade

100

81.599999

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

Ausgegebene Aktien

4.462.229.293

Dividendenrendite

Kurs-Gewinn-Verhältnis

4,52

Gewinn pro Aktie (EPS)

18,75

Erlöse

232,26B

Nettogewinn

83,68B

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.novonordisk.com

Hauptsitz

Bagsvaerd, Dnk

Gegründet

Novo Nordisk is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker NOVA. The last closing price for Novo Nordisk was 100,00 €. Over the last year, Novo Nordisk shares have traded in a share price range of 0,00 € to 0,00 €.

Novo Nordisk currently has 4.462.229.293 shares in issue. The market capitalisation of Novo Nordisk is 446,22 € billion. Novo Nordisk has a price to earnings ratio (PE ratio) of 4.52.

Success of the Simplified Cash Tender Offer for the Shares & bons de souscription d’actions of Novagali Pharma SA by Santen...

Regulatory News: Santen Pharmaceutical Co., Ltd. (“Santen”) and Novagali Pharma SA (“Novagali”) announced today the success of the simplified cash tender offer for the...

Novagali Pharma: Revenue for the 3rd quarter of 2011

Regulatory News: Novagali Pharma (Paris:NOVA), a pharmaceutical company that develops and markets innovative ophthalmic products, today announces its revenue for the first...

Santen Pharmaceutical Co., Ltd. Completes the Acquisition of a Controlling Interest in Novagali Pharma S.A.

Regulatory News: Following the press release of September 28, 2011, in accordance with articles 223-2 and 223-6 of the general regulations of the French Autorité des...

Signing of an Acquisition of a Controlling Interest in Novagali Pharma S.A. by Santen Pharmaceutical Co., Ltd.

Regulatory News: Santen Pharmaceutical Co., Ltd. (Osaka, Ticker Code 4536JP) (hereafter “Santen”), a leading Japanese pharmaceutical company, and Novagali Pharma S.A...

Novagali Pharma Reports Positive Results in Phase II Study for Catioprost® vs. Travatan Z® in Patients with Glaucoma & Ocul...

Regulatory News: Novagali Pharma (Paris:NOVA) announced today US phase II positive results on the efficacy and safety of Catioprost® in patients with glaucoma and...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

NOVA - Frequently Asked Questions (FAQ)

What is the current Novo Nordisk share price?

The current share price of Novo Nordisk is 81,40 €

How many Novo Nordisk shares are in issue?

Novo Nordisk has 4.462.229.293 shares in issue

What is the market cap of Novo Nordisk?

The market capitalisation of Novo Nordisk is EUR 446,22B

What is the 1 year trading range for Novo Nordisk share price?

Novo Nordisk has traded in the range of 0,00 € to 0,00 € during the past year

What is the PE ratio of Novo Nordisk?

The price to earnings ratio of Novo Nordisk is 4,52

What is the cash to sales ratio of Novo Nordisk?

The cash to sales ratio of Novo Nordisk is 1,63

What is the reporting currency for Novo Nordisk?

Novo Nordisk reports financial results in DKK

What is the latest annual turnover for Novo Nordisk?

The latest annual turnover of Novo Nordisk is DKK 232,26B

What is the latest annual profit for Novo Nordisk?

The latest annual profit of Novo Nordisk is DKK 83,68B

What is the registered address of Novo Nordisk?

The registered address for Novo Nordisk is NOVO ALLE, BAGSVAERD, DK-2880

What is the Novo Nordisk website address?

The website address for Novo Nordisk is www.novonordisk.com

Which industry sector does Novo Nordisk operate in?

Novo Nordisk operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
GX6TPI Composites Inc	2,258 € (92,66%)	18,75k
LTIAptose Biosciences Inc	0,278 € (68,48%)	430,65k
36GGBM Resources Limited	0,008 € (60,00%)	102,8k
7ZGAskari Metals Ltd	0,0104 € (48,57%)	155k
VOPInvestigator Resources Ltd	0,017 € (47,83%)	23,1k
PHPNGalectin Therapeutics Inc	0,90 € (-53,61%)	3,69k
AWY0Percheron Therapeutics Ltd	0,0025 € (-44,44%)	658,15k
H5EHelma Eigenheimbau Ag	0,04 € (-40,83%)	29,35k
7KOCullinan Metals Corp	0,0076 € (-35,59%)	3,5k
W47Grid Battery Metals Inc	0,01 € (-35,48%)	1.000
AXIAtos SE	0,0021 € (0,00%)	474,93M
D7GNel ASA	0,253 € (-0,16%)	4,33M
RQ0DWave Quantum Inc	6,38 € (3,44%)	2,96M
R9BDeFi Technologies Inc	2,67 € (10,56%)	2,3M
3CPXiaomi Corporation	3,886 € (2,47%)	2,29M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Novo Nordisk (NOVA)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Novo Nordisk

NOVA Neueste Nachrichten

Success of the Simplified Cash Tender Offer for the Shares & bons de souscription d’actions of Novagali Pharma SA by Santen...

Novagali Pharma: Revenue for the 3rd quarter of 2011

Santen Pharmaceutical Co., Ltd. Completes the Acquisition of a Controlling Interest in Novagali Pharma S.A.

Signing of an Acquisition of a Controlling Interest in Novagali Pharma S.A. by Santen Pharmaceutical Co., Ltd.

Novagali Pharma Reports Positive Results in Phase II Study for Catioprost® vs. Travatan Z® in Patients with Glaucoma & Ocul...

Novagali: Availability of the 2011 half-year financial report

Novagali: 2011 First-Half Results

Novagali : Revenue for the first half of 2011

Novagali Pharma: Supervisory Board Strengthened Significantly

Novagali Pharma and Ardeo Sign an Exclusive Distribution Agreement for Nova23041 in the United States and Canada

NOVA - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Novo Nordisk (NOVA) Börsenkurse

Novo Nordisk (NOVA)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Novo Nordisk

NOVA Neueste Nachrichten

NOVA - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE